----0 - getGroupsByUser
Array
(
    [0] => stdClass Object
        (
            [title] => Public
        )

)

----0 - getAuthorisedViewLevels
Array
(
    [0] => 1
    [1] => 1
)

----0 - groups
Array
(
    [0] => 1
)

Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

News

New edition of the iCMLf Newsletter - available now

iCMLf Newsletter I 2018June 2018 - We are delighted to present to you the new edition of the iCMLf Newsletter that features the Foundation's activities and programs over the last six months. 
Download the pdf file here
Contents overview:

  • News from the iCMLf - supporters and experts from the Foundation
  • iCMLf progam update - news from our core programs and activities
  • Summary of key publications - 5-year results from the phase II PACE trial
  • iCMLf educational services - new interactive eLearning tool for CML

iCMLf Forum 2018 - Perspectives on treating CML from Ghana and Thailand

iCMLf Forum 2018 Hughes 1

January 2019 - On the iCMLf website you will now find webstreams of all the presentations held at the 2018 iCMLf Forum for Physicians from Emerging Regions.

  • Perspectives on treating CML in pregnant patients
    Professor Dragana Milojkovic (UK) and Dr Amma Benneh-Akwasi Kuma (Ghana)
  • Perspectives on treating CML in pediatric patients
    Professor Meinolf Suttorp (Germany)
  • Perspectives on adherence during TKI therapy
    Professor Saengsuree Jottar (Thailand)

ASH 2018 Conference Coverage on CML

CML Summary ASH 2018 Kopie

Expert interviews and scientific summary available

January 2019 - The iCMLf is pleased to present to you conference coverage from the CML education session at the American Society of Hematology Annual Meeting (ASH 2018) in San Diego. This includes expert video interviews with speakers on their perspectives on the session and a scientific summary report of this session and relevant abstracts.

These summaries have been created by Springer Healthcare IME, Springer’s independent medical education unit and are brought to you with support from Bristol Myers Squibb.

iCMLf Diagnosis and Testing Program - Apply now for 2018 grants

May 2018 - The iCMLf Diagnosis and Testing Program offers seeding grants to hematology institutions in emerging economic regions. The aim of the program is to facilitate the diagnosis, testing and long-term disease monitoring of CML patients in emerging economic regions where it is either limited, or not currently available.

Over six years the iCMLf have awarded 48 grants to enable CML diagnostics to be expanded and enhanced at a local level. This gives both physicians and patients the knowledge to make meaningful decisions on treatment. In 2018 the Foundation will offer 10 grants with funding of up to $10,000.

Applications will close on the 30th of July 2018. Proposals are welcome to arlene@cml-foundation.org.
Read more for further information on how to apply.

Nominate for the 2019 iCMLf prizes

GoldmanPrize medal RGB reduc

November 2018 - The Foundation is celebrating its 10th anniversary next year. This also marks the tenth anniversary of our tradition to recognise and reward personal contributions and outstanding achievements to our understanding of the biology of CML and to improving the management of patients with CML around the world. It all started with the first iCMLf Rowley Prize awarded to Professor Brian Druker in 2009. This was followed by the introduction of the iCMLf Goldman Prize in 2014 and the iCMLf Prize in 2015.

We will continue this tradition next year. You are now welcome to nominate a colleague, or mentor for one of the 2019 prizes. Who would you like to see awarded the iCMLf prizes next year?

Michael Mauro and Giuseppe Saglio join the iCMLf Board of Directors

April 2018 - We are delighted to announce new members of the iCMLf board of Directors and Scientific Advisory Committee. The iCMLf was formed to assist the CML scientific community by leading haematologists in the field. As such, the trustees and advisors of the Foundation are all key CML experts. These people are critical to the strength of the iCMLf giving most generously of their time and expertise. In 2018 we welcome 2 new Directors and 4 new advisors to the iCMLf.